Recanati Miller Transplant Institute — New York, New York

Recanati Miller Transplant Institute is a clinical research site located in New York, New York, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Recanati Miller Transplant Institute has participated in 1 clinical trials.

Therapeutic areas: Graft Rejection.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Recanati Miller Transplant Institute?

Recanati Miller Transplant Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Recanati Miller Transplant Institute conducted?

Recanati Miller Transplant Institute has 1 clinical trials on record. Their work covers Graft Rejection.

Is Recanati Miller Transplant Institute accredited by Crixeo Health?

Recanati Miller Transplant Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Recanati Miller Transplant Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.